METACARE CO., Ltd. (KRX:118000)
329.00
-2.00 (-0.60%)
Feb 20, 2025, 9:00 AM KST
METACARE CO. Revenue
METACARE CO. had revenue of 4.86B KRW in the quarter ending September 30, 2024, with 14.23% growth. This brings the company's revenue in the last twelve months to 57.57B, up 241.78% year-over-year. In the year 2023, METACARE CO. had annual revenue of 55.75B with 191.91% growth.
Revenue (ttm)
57.57B
Revenue Growth
+241.78%
P/S Ratio
0.83
Revenue / Employee
2.62B
Employees
22
Market Cap
54.05B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 55.75B | 36.65B | 191.91% |
Dec 31, 2022 | 19.10B | 484.98M | 2.61% |
Dec 31, 2021 | 18.61B | 11.99B | 181.12% |
Dec 31, 2020 | 6.62B | -49.53B | -88.21% |
Dec 31, 2019 | 56.16B | 22.57B | 67.19% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
SK Biopharmaceuticals | 511.33B |
Yuhan | 2,008.84B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanmi Science | 1,283.65B |
Hanall Biopharma | 134.24B |